skip to Main Content

Medicare Part D

Our Medicare Part D
Video Series

As the 2023 bid cycle begins, life sciences companies must understand how the Part D market is evolving and how health plans approach Part D formularies and benefit designs. This video series features Avalere leaders with deep expertise on opposing sides of Part D plan/manufacturer formulary negotiations. In the first video of the series, hear from Ryan Urgo and Neil Lund about:

  • Membership trends in standalone prescription drug plans and Medicare Advantage prescription drug plans
  • The rise in plan spending on specialty drugs in relation to brands and generics
  • How these trends impact government payments, plan decision-making, and the push for program reform

Customized Solutions

Our team has the tools and the expertise to guide you through the complexities of Medicare Part D. Our solutions help you chart a path to reach your goals.
Bid Modeling and Analytics
Part D Landscape and Formulary Analysis
Plan Liability and Net Price Estimates
Policy Impact and Scenario Planning
Policy Modeling and Scoring
Pricing, Reimbursement, and Access Strategy
Back To Top